🔎 Trials Near Me

Gara Jalqabaatti › Poliiraadiikuluunyuuropaatii Demiyelinaatarii Inflammatoorii Keessummaa › California

Qorannoo klinikaalii Poliiraadiikuluunyuuropaatii Demiyelinaatarii Inflammatoorii Keessummaa California keessatti

Qorannoo 11 Poliiraadiikuluunyuuropaatii Demiyelinaatarii Inflammatoorii Keessummaa f California keessatti hirmaatuu jiru.

Magaalota California keessatti

Takkalaa qorannoo (Ingiliffa)

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Site Number - 1618, Carlsbad
  • Site Number - 1637, Mission Hills
  • Site Number - 1619, Orange
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07032662

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  • Samir Macwan, M.D., Inc. (S corporation), Rancho Mirage
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07091630

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  • Samir Macwan, M.D., Inc., Rancho Mirage
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06920004

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Keck School of Medicine of University of Southern California- Site Number : 8400002, Los Angeles
  • University of California Irvine Medical Center- Site Number : 8400007, Orange
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06290141

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

  • TG Therapeutics Investigational Trial Site, La Jolla
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06680037

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  • GC2402 Study Site 104, Rancho Mirage
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07540221

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  • Clinical Study Site, Los Angeles
  • Clinical Study Site, San Francisco
  • Clinical Study Site, San Francisco
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06858579

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford Neuroscience Health Center, Palo Alto
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT07304154

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • University of California San Diego, La Jolla
  • California Pacific Medical Center, San Francisco
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT06798012

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • Stanford Neuroscience Health Center, Palo Alto
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06747351

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

  • Samir Macwan MD Inc, Rancho Mirage
  • Neuro/Psych Sleep Clinic, San Francisco
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Sad-2025 · NCT06538064

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.